Comparison of Two SARS-CoV-2 Rapid Antigen Test
DOI:
https://doi.org/10.24293/ijcpml.v30i2.2098Keywords:
COVID-19, rapid antigen, RT-PCR, SARS-CoV-2Abstract
The Coronavirus Disease 2019 (COVID-19) pandemic continues to spread worldwide. A quick, simple, and accurate test to diagnose COVID-19 is essential for this situation. This study aims to evaluate and compare the rapid antigen examination of SARS-CoV-2 with Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) in detecting SARS-CoV-2. A retrospective study with a cross-sectional approach using medical record data from suspected, controlled, and confirmed COVID-19 patients whose samples were taken simultaneously for rapid antigen examination of SARS-CoV-2 (SD-Biosensor and Lungene) and RT-PCR at Labuang Baji Hospital, Makassar from September 2020-September 2021. Each instrument's sensitivity, specificity, negative predictive value, and positive predictive value were analyzed with the Receiver Operating Characteristics (ROC) curve method. This study obtained data from 312 rapid antigen tests for SARS-CoV-2, divided into two categories, 98 using Lungene and 214 using SD-Biosensor. Rapid antigen Lungene had a sensitivity of 71.4%, specificity of 71.4%, an accuracy of 71.4%, and a 31 reactive result in CT value. The SD-Biosensor Rapid antigen had a sensitivity of 62.6%, a specificity of 99.1%, an accuracy of 82.2%, and a 26 reactive result in CT value. In summary, the sensitivity of rapid antigen Lungene is higher than SD-Biosensor. Specificity and accuracy of rapid antigen SD-Biosensor higher than Lungene. Rapid test antigen SARS-CoV-2 has the potential to be a screening test for COVID-19 as long as the sampling time is right.
Downloads
References
Yurianto A, Bambang W, Pritasari K, Kadir A, Ginting KA, dkk. Pendahuluan, surveilans dan respon, dan pengelolaan spesimen dan konfirmasi laboratotium. In: Pedoman pencegahan dan pengendalian Coronavirus Disease (COVID-19) Revisi ke-5., Jakarta, Kementerian Kesehatan Republik Indonesia, 2020; 11- 44: 72-80.
Burhan E, Susanto D, Nasution A, Ginanjar E, Pitoyo Wicaksono, dkk. Pendahuluan dan Coronavirus. In: Diagnosis dan penatalaksanaan pneumonia COVID-19 di Indonesia. Jakarta, Perhimpunan Dokter Paru Indonesia, 2020; 1-3.
Wang Zhou, Qiang Wang, Ke Hu. Learn about Coronavirus. In: A handbook of 2019-nCoV pneumonia control and prevention. Wuhan, Hubei Science and Technology Press, 2020; 10-21.
Habibzadeh Parham, Stoneman K Emily. The novel Coronavirus: A birds eye view. International Journal of Occupational and Environmental Medicine, 2020; 11(2): 65-71.
Tim Satgas pencegahan penyebaran COVID-19. Peta sebaran COVID-19. Available on: https://covid19.go.id/peta-sebarancovid19 (accessed Augst 2, 2021).
World Health Organization. Rational use of Personal Protective Equipment (PPE) for Coronavirus Disease (COVID-19). Available from: WHO/2019-nCoV/IPC PPE use/2020.2 (accessed March 19, 2020).
Center for Disease Control and Prevention (CDC). Interim guidance for rapid antigen testing for SARS-CoV-2. 2020. Available from: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/grc-742255 (accessed September 4, 2020).
Jalali M, Zaborowska J, Jalali M. The polymerase chain reaction: PCR, qPCR, and RT-PCR [Internet]. Basic science methods for clinical researchers. US, Elsevier Inc, 2017; 1–18.
Yu K, Karwowska S, Sharma A, Liesenfeld O, Scudder SA. Polymerase chain reaction [Internet]. Companion and complementary diagnostics: From biomarker discovery to clinical implementation. US, Elsevier Inc, 2019; 111–133.
Rahman MT, Uddin MS, Sultana R, Moue A, Setu M. Polymerase Chain Reaction (PCR): A Short Review. Anwer Khan Mod Med Coll J. 2013;4(1):30–6.
Joshi M, Deshpande JD. Polymerase chain reaction: Methods, principles and application. Int J Biomed Res, 2011; 2(1): 81-97.
Keputusan Menteri Kesehatan Republik Indonesia No.HK.01.07/Menkes/413/2020 tentang pedoman pencegahan pengendalian COVID-19. Jakarta, 2020; 75-83.
Heid AC, Stevens J, Livak KJ, Williams M. Real time quantitative PCR. Genome Reseacrh. 2012. Available from: Real time quantitative PCR. (cshlp.org) (accessed August 2, 2021).
Keputusan Menteri Kesehatan Republik Indonesia. Tentang penggunaan rapid diagnostic test antigen dalam pemeriksaan Coronavirus Disease 2019 (COVID-19). Jakarta, 2021.
Perhimpunan Dokter Spesialis Patologi Klinik dan Kedokteran Laboratorium Indonesia (PDS PatKLIn). Revisi panduan tata laksana pemeriksaan rapid test antigen. Jakarta, 2020.
Chaimayo Chutikarn, Kaewnaphan B, Tanlieng N, Athipanyasilp N, Sirijatuphat R, et al. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Thailand: Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2020; 17(1): 177.
Pena Monica, Ampuero M, Garces C, Gaggero A, Garcia P, et al. Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals. Chili, Elsevier, 2021; 107: 201-204.
Mak CK Gannon, Cheng KC, Lau Sy S, Wong Ky K, Lau SC, et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. China, Elsevier, 2020; 129.
Chavolla YB Omar, Antonio-Villa NE, Fernandez L, Guerra EC, Fermin-Marthenz CA, et al. Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data. Mexico, Plus One, 2021;16(8): e0256447.
SD-Biosensor. Standar Q COVID-19 IFU insert kit. Korea, 2020.
Lungene. COVID-19 antigen rapid test cassette. Hangzhou Clongene Biotech.Co. China, 2020.
Museyaroh, Wardhani P, Aryati. Validity of chemiluminescent immunoassay serology test for anti-Sars-Cov-2 antibodies IgM and IgG. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2021; 28(1): 26-30.
Downloads
Submitted
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
